Cogent Biosciences Inc (COGT)

Stock-Based Compensation

$17.11M

Quarterly · Period ending: · USD

COGT logo

COGT Stock-Based Compensation

Latest reported$17.11M
COGT Quarterly Stock-Based Comp ($1.68M → $17.11M)
High-resolution chart · PNG

COGT stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
17,107,000
16,908,000
15,751,000
10,604,000
9,716,000
10,008,000
9,977,000
10,358,000
10,012,000
9,393,000
8,851,000
8,757,000
7,163,000
5,850,000
5,037,000
4,622,000
0
4,175,000
3,852,000
3,463,000
2,590,000
1,781,000
866,000
3,512,000
870,000
769,000
842,000
788,000
885,000
726,000
902,000
860,000
847,000
479,000
460,000
299,000
282,000
300,000
7,318,000
1,681,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.